S Foote.
Experienced Member
- Reaction score
- 66
jimmystanley said:S Foote. said:Bryan said:jimmystanley said:bryan...
follicles destined to become male pattern baldness follicles, do `NOT' `directly' RESPOND' to exposure of androgens by turning into male pattern baldness follicles!
S Foote.
so this means at the time we get androgen activity in our scalp it does not trigger certain follicles to become male pattern baldness follicles? if so is it because they are already male pattern baldness follicles?
I think what the studies show, is an in-direct effect of androgens in-vivo as the `converting' factor.
The in-vitro tests show that the exposure to androgens of `any' kind of follicle sample, does `NOT' change their pre-existing growth characteristics. We know that androgens `DO' change the growth characteristics of hair follicles, normal terminal scalp follicles to male pattern baldness follicles for example. But the in-vitro tests clearly show that the `CHANGE' is not caused by a `direct' effect of androgens.
So, knowing androgens are the cause of the `change' in male pattern baldness follicles, this just leaves some kind of `in-direct in-vivo' action of androgens!
In this thread, people are talking about the `up-regulation', or increased production of androgen receptors within follicle cells in response to finasteride/dutasteride.
Everyone seems to accept that this is a `design' reaction by these cells to maintain the androgen effect within the follicle cells in the face of falling DHT levels.
There is no reason to suspect that this is not a succesful, `well evolved' tactic. So it seems that this up-regulation of receptors in follicle cells `must' cancel out the major effect of finasteride/dutasteride in the follicle cells `THEMSELVES'!
So knowing that these drugs `work' at all, `MUST' support a more important `in-direct' action of DHT in-vivo, and that any `direct' androgen effect within follicles is not that rellevant in-vivo!
S Foote.